Background illustration for clinical trials search

Paid Clinical Trials Overland Park

Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 722

Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection

for

Deep Venous Thrombosis

Location: Leawood KS

Sponsor: Swanson Center

Sex: All

Age: 18+

Code: NCT02123550

Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

for

Secondary Progressive Multiple Sclerosis

Location: Roeland Park KS, St Louis MO, Oklahoma City OK,

Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07299019

Phase3, Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for

Multiple Sclerosis (MS) Primary Progressive

Location: Roeland Park KS, Kansas City KS, St Louis MO,

Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase3, Recruiting

Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices

for

Fusion of Spine, Sacroiliac; Fusion

Location: Overland Park KS, Edina MN

Sponsor: Spinal Simplicity LLC

Sex: All

Age: 18+

Code: NCT07204288

Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

for

Complex Regional Pain Syndrome Type I

Location: Overland Park KS, Little Rock AR, Orland Park IL,

Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07210515

Phase3, Recruiting

New

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for

Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma

Location: Westwood KS, Overland Park KS, Kansas City KS,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase3, Recruiting

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

for

Peripheral T-cell Lymphoma

Location: Westwood KS, Dallas TX, Louisville KY, Atlanta GA,

Sponsor: CerRx, Inc.

Sex: All

Age: 18+

Code: NCT02495415

Phase2, Recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

for

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer,

Location: Westwood KS, St Louis MO

Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06374459

Phase1, Phase2, Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for

Solid Tumor

Location: Westwood KS, Iowa City IA, Houston TX, Detroit MI,

Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase1, Phase2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

for

Non-Small Cell Lung Cancer

Location: Westwood KS, Kansas City MO, Omaha NE, St Louis MO,

Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT05899608

Phase3, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for

Breast Cancer

Location: Westwood KS, Kansas City MO, Sioux Falls SD,

Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

for

Myeloproliferative Neoplasms

Location: Westwood KS, St Louis MO, Nashville TN, Houston TX,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06034002

Phase1, Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

for

B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy,

Location: Westwood KS, St Louis MO, San Antonio TX,

Sponsor: CRISPR Therapeutics AG

Sex: All

Age: 18+

Code: NCT05643742

Phase1, Phase2, Recruiting

Vitamin D for Prostate Endocrine Therapy

for

Stage I Prostate Cancer AJCC v8,

Location: Westwood KS, Overland Park KS, Kansas City KS,

Sponsor: University of Rochester

Sex: Male

Age: 50+

Code: NCT05838716

Phase3, Recruiting

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

for

Nodular Lymphocyte Predominant B-Cell Lymphoma,

Location: Westwood KS, Overland Park KS, Kansas City KS,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05886036

Phase2, Recruiting

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

for

Head and Neck Squamous Cell Carcinoma

Location: Westwood KS, Springfield MO, St Louis MO, Peoria IL,

Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06163534

Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for

Advanced Melanoma

Location: Westwood KS, Minneapolis MN, Chicago IL, Dallas TX,

Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,

Location: Westwood KS, Lincoln NE, Des Moines IA, Dallas TX,

Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for

AL Amyloidosis

Location: Westwood KS, Kansas City KS, Bellevue NE, Omaha NE,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer

for

HER2-positive Breast Cancer

Location: Kansas City KS, Overland Park KS, Kansas City MO,

Sponsor: Qamar Khan

Sex: Female

Age: 18+

Code: NCT03238495

Phase2, Recruiting

Paid Clinical Trials Overland Park

Filter results

Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Interested in new trials?

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Vitamin D for Prostate Endocrine Therapy

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer